MASS
908 Devices IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$252.69M
P/E Ratio
—
EPS
$-0.93
Beta
0.53
52W High
$9.34
52W Low
$3.61
50-Day MA
$6.44
200-Day MA
$6.65
Dividend Yield
—
Profit Margin
34.70%
Forward P/E
—
PEG Ratio
—
About 908 Devices Inc
908 Devices Inc. develops and sells measuring devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and Asia Pacific. The company is headquartered in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | $56.20M |
| Gross Profit (TTM) | $28.72M |
| EBITDA | $-20.75M |
| Operating Margin | -17.30% |
| Return on Equity | -25.80% |
| Return on Assets | -9.02% |
| Revenue/Share (TTM) | $1.56 |
| Book Value | $3.96 |
| Price-to-Book | 1.72 |
| Price-to-Sales (TTM) | 4.50 |
| EV/Revenue | 2.469 |
| EV/EBITDA | -3.15 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -7.70% |
| Shares Outstanding | $37.38M |
| Float | $22.97M |
| % Insiders | 8.83% |
| % Institutions | 86.63% |
Analyst Ratings
Consensus ($10.00 target)
4
BuyData last updated: 4/8/2026